Waltham, MA - Digoxin use is linked to mortality in patients with end-stage renal disease (ESRD), according to the results of a retrospective cohort study reported online June 24, 2010 in the Journal ...

Digoxin use among patients who are on hemodialysis (HD) may increase their risk of death, especially if they have low predialysis potassium levels, a study showed. HD patients who used digoxin had a ...

Patients with atrial fibrillation (AFib) who are given digoxin to control their symptoms have an increased risk of death, whether or not they have a diagnosis of heart failure, compared with patients ...

Digoxin is eliminated mainly by the kidney through glomerular filtration and P-glycoprotein (P-gp) mediated tubular secretion. Toddlers and young children require higher doses of digoxin per kilogram ...

Most of the estimated 400 000 Canadians who experience heart failure are 65 years of age or older. Heart failure is the most frequent reason for hospital admission for older adults. Admission for ...

KAIMRC researchers have shown that a drug, commonly used to treat various types of heart failure, appears to increase mortality risk in certain groups of patients when it is used in place of current ...

Digoxin is used to treat heart failure as well as arrhythmias Research suggests a common heart drug used by thousands in the UK is linked with a significant increase in deaths. But experts insist the ...

Digoxin 0.25mg/mL; soln for IV or IM inj. Lanoxin (digoxin) Injection, 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL); box of 10 ampules or 10 vials. Lanoxin (digoxin) Injection Pediatric, 100 ...

Digoxin 0.1mg/mL; soln for IV or IM inj. Lanoxin Tablets: Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [See USP Controlled Room Temperature] in a dry place and protect from ...